Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis
Background Recent studies have demonstrated that earlier time-of-day infusion of immune checkpoint inhibitors (ICIs) is associated with longer progression-free survival (PFS) and overall survival (OS) among patients with metastatic melanoma and non-small cell lung cancer. These data are in line with...
Saved in:
| Main Authors: | Haydn Kissick, Viraj A Master, Mehmet A Bilen, Zachary S Buchwald, Mohammad K Khan, Caroline S Jansen, Michael C Lowe, Jimmy S Patel, Yena Woo, Amber Draper, Jennifer W Carlisle, Pasquale F Innominato, Francis A Lévi, Layla Dhabaan, David C Qian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-03-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/12/3/e008011.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimizing circadian drug infusion schedules towards personalized cancer chronotherapy.
by: Roger J W Hill, et al.
Published: (2020-01-01) -
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors
by: Julie M. Shabto, et al.
Published: (2020-04-01) -
“Teamwork Makes the Dream Work”: Infusing Interprofessional Education Into Human Services Curriculum and Training
by: Nicholas Schmoyer, et al.
Published: (2023-04-01) -
Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response.
by: Haydn T Kissick, et al.
Published: (2014-01-01) -
Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survival
by: Rishi R. Sekar, et al.
Published: (2016-04-01)